Galectin Therapeutics Inc. (GALT) is a clinical-stage biopharmaceutical company based in Norcross, Georgia, specializing in the discovery and development of innovative therapies targeting fibrotic diseases, cancer, and other severe medical conditions. The company's proprietary technology focuses on galectin proteins, which play critical roles in disease progression and tissue inflammation, positioning Galectin Therapeutics to address significant unmet medical needs. With a robust pipeline and strategic research initiatives, GALT aims to advance its therapeutic candidates towards FDA approval, thereby enhancing treatment options for patients confronting challenging health issues.
Click "Analyze" to generate stock analysis
GALT Price Trend and Signals
GALT Option Volumes & Open Interests (aggregated)
GALT Put Call Ratios and IV (aggregated)
GALT Financials
2025-10-28Neutralvolume_signal
Abnormal volume detected compared to 5-day moving average.
2025-10-28Neutralvolume_signal
Abnormal volume detected compared to 10-day moving average.
2025-10-28Neutralvolume_signal
Abnormal volume detected compared to 20-day moving average.
2025-10-28Neutralvolume_signal
Abnormal volume detected compared to 3 mon moving average.